Şeyda Betül Fındık
Şeyda Betül Fındık has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Cemre Boşnak
Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine , Ankara
1 shared publication - Eda Karadogan
Hacettepe University Faculty of Medicine Department of Public Health Division of Epidemiology
1 shared publication - Engin Turkay Yilmaz
Department of Orthopedics and Traumatology, Alaca State Hospital, 19600 Corum, Türkiye
1 shared publication - Gazi Huri
Faculty of Medicine, Department of Orthopedics and Traumatology, Hacettepe University, Ankara, Turkey
1 shared publication - Gökhan Metan
Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine , Ankara
1 shared publication - Muhammed Atay
Faculty of Medicine Graduate Program, Hacettepe University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 4 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8597
ZTE MRI for Rotator Cuff Tear Arthropathy: Integrated Bone–Muscle Analysis and Its Association with Pseudoparesis
Background/Objectives: Evaluating glenoid changes in rotator cuff tear arthropathy (RCTA) is crucial for preoperative planning. MRI with zero echo time (ZTE) sequence, which produces CT-like images, allows for the assessment of osseous morphology as well as factors contributing to pseudoparesis in RCTA patients. Methods: In this retrospective study, using 3T MRI, glenoid version, glenoid vault depth, humeral subluxation index, humeral head medialization, critical shoulder angle, glenoid best-fit circle width, glenoid best-fit circle bone loss ratio (GBLR), and anterior, central, and posterior glenoid bone loss were measured on reformatted 3D ZTE images in 43 shoulders independently by three observers. The same measurements were repeated by one observer after 10 days. Muscle cross-sectional areas were measured. Patients’ active ROMs, American Shoulder and Elbow Surgeons (ASES), and Constant–Murley scores were recorded. Patients unable to perform 90° forward elevation were classified as the pseudoparesis group. Results: Interobserver agreements were good to excellent, except for glenoid vault depth, anterior bone loss, and GBLR. Intraobserver agreements were good to excellent. The pseudoparesis group showed significantly less subscapularis muscle cross-sectional area (p = 0.006). Moderate correlations were found between subscapularis cross-sectional area and forward elevation, abduction, and internal rotation ([r = 0.471, p = 0.001]; [r = 0.447, p = 0.003]; [r = 0.464, p = 0.002], respectively). Moderate negative correlations were found between anterior glenoid loss and forward elevation (r = −0.411, p = 0.006) and abduction (r = −0.475, p = 0.001). Conclusions: MRI with ZTE sequence demonstrated good reliability for assessing osseous morphology in shoulders with RCTA. Glenoid anterior bone loss and loss of subscapularis muscle are both associated with pseudoparesis.
- 4 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8597
Open AccessZTE MRI for Rotator Cuff Tear Arthropathy: Integrated Bone–Muscle Analysis and Its Association with Pseudoparesis
Background/Objectives: Evaluating glenoid changes in rotator cuff tear arthropathy (RCTA) is crucial for preoperative planning. MRI with zero echo time (ZTE) sequence, which produces CT-like images, allows for the assessment of osseous morphology as well as factors contributing to pseudoparesis in RCTA patients. Methods: In this retrospective study, using 3T MRI, glenoid version, glenoid vault depth, humeral subluxation index, humeral head medialization, critical shoulder angle, glenoid best-fit circle width, glenoid best-fit circle bone loss ratio (GBLR), and anterior, central, and posterior glenoid bone loss were measured on reformatted 3D ZTE images in 43 shoulders independently by three observers. The same measurements were repeated by one observer after 10 days. Muscle cross-sectional areas were measured. Patients’ active ROMs, American Shoulder and Elbow Surgeons (ASES), and Constant–Murley scores were recorded. Patients unable to perform 90° forward elevation were classified as the pseudoparesis group. Results: Interobserver agreements were good to excellent, except for glenoid vault depth, anterior bone loss, and GBLR. Intraobserver agreements were good to excellent. The pseudoparesis group showed significantly less subscapularis muscle cross-sectional area (p = 0.006). Moderate correlations were found between subscapularis cross-sectional area and forward elevation, abduction, and internal rotation ([r = 0.471, p = 0.001]; [r = 0.447, p = 0.003]; [r = 0.464, p = 0.002], respectively). Moderate negative correlations were found between anterior glenoid loss and forward elevation (r = −0.411, p = 0.006) and abduction (r = −0.475, p = 0.001). Conclusions: MRI with ZTE sequence demonstrated good reliability for assessing osseous morphology in shoulders with RCTA. Glenoid anterior bone loss and loss of subscapularis muscle are both associated with pseudoparesis.
- Open Access
- 25 September 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e146
The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli
Objective: This study aims to assess the impact of hospital-specific guidelines on the optimal utilization of carbapenems and to examine their effects on patient outcomes. Design: Quasi-experimental study. Setting: Tertiary care hospital in Turkey where infectious diseases (IDs) consultation and antibiotic approval are mandatory for carbapenem use. Participants: All inpatients ≥18 years of age who received a carbapenem for at least 24 hours during the study periods were enrolled. Intervention: Hospital-specific treatment guidelines were introduced in April 2019. The control group was the year 2018, when there were no guidelines (pre-GP). The year 2020 was analyzed as the intervention period (post-GP). Results: A total of 678 patients were analyzed, 326 in the pre-GP period and 352 in the post-GP period. Following guideline implementation, there was a significant increase in appropriate carbapenem use (49.1% in pre-GP vs 71.9% in post-GP, P < .001). The duration of carbapenem use decreased significantly (P = .019). However, there was no significant change in the incidence of new infection episodes within the subsequent 30 days (27.6% in pre-GP vs 28.3% in post-GP), or in the length of hospitalization [median (25%–75%) = 28 (16–46) in pre-GP, 28 (15–47.5) in post-GP, P = .678]. Mortality rates were similar at day 7 post-GP (1.7%) compared to pre-GP (0.03%) (P = .125). Conclusions: The implementation of guidelines increased the appropriate utilization of carbapenems, without resulting in extended hospital stays or recurrent episodes. Despite an increased number of patients admitted to the ICU during the latter period, infection-related mortality rates remained comparable.
- 25 September 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e146
Open AccessThe impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli
Objective: This study aims to assess the impact of hospital-specific guidelines on the optimal utilization of carbapenems and to examine their effects on patient outcomes. Design: Quasi-experimental study. Setting: Tertiary care hospital in Turkey where infectious diseases (IDs) consultation and antibiotic approval are mandatory for carbapenem use. Participants: All inpatients ≥18 years of age who received a carbapenem for at least 24 hours during the study periods were enrolled. Intervention: Hospital-specific treatment guidelines were introduced in April 2019. The control group was the year 2018, when there were no guidelines (pre-GP). The year 2020 was analyzed as the intervention period (post-GP). Results: A total of 678 patients were analyzed, 326 in the pre-GP period and 352 in the post-GP period. Following guideline implementation, there was a significant increase in appropriate carbapenem use (49.1% in pre-GP vs 71.9% in post-GP, P < .001). The duration of carbapenem use decreased significantly (P = .019). However, there was no significant change in the incidence of new infection episodes within the subsequent 30 days (27.6% in pre-GP vs 28.3% in post-GP), or in the length of hospitalization [median (25%–75%) = 28 (16–46) in pre-GP, 28 (15–47.5) in post-GP, P = .678]. Mortality rates were similar at day 7 post-GP (1.7%) compared to pre-GP (0.03%) (P = .125). Conclusions: The implementation of guidelines increased the appropriate utilization of carbapenems, without resulting in extended hospital stays or recurrent episodes. Despite an increased number of patients admitted to the ICU during the latter period, infection-related mortality rates remained comparable.